B. Schneider

发表

Optimal Scheduling of Bevacizumab and Pemetrexed/cisplatin Dosing in Non-Small Cell Lung Cancer

F. Barlesi, J. Mochel, J. Ciccolini, 2019, bioRxiv.

Optimal Scheduling of Bevacizumab and Pemetrexed/Cisplatin Dosing in Non‐Small Cell Lung Cancer

F. Barlesi, J. Mochel, J. Ciccolini, 2019, CPT: pharmacometrics & systems pharmacology.

Veterinary Considerations for the Theoretical Resurrection of Extinct Species

L. Cherep, M. Jefferson, Joe S. Smith, 2018 .

In vitro Cytotoxicity and Pharmacokinetic Evaluation of Pharmacological Ascorbate in Dogs

J. Mochel, G. Buettner, B. Wagner, 2019, Front. Vet. Sci..

CULTURE AND MAINTENANCE OF URINE-DERIVED, 3-DIMENSIONAL CANINE TRANSITIONAL CELL CARCINOMA ORGANOIDS

Jean-Sébastien Palerme, J. Mochel, S. Thenuwara, 2021, bioRxiv.

Pharmacokinetics of Intravenous, Intramuscular, Oral, and Transdermal Administration of Flunixin Meglumine in Pre-wean Piglets

J. Coetzee, J. Mochel, L. Karriker, 2020, Frontiers in Veterinary Science.

Nonlinear mixed-effects pharmacokinetic modeling of the novel COX-2 selective inhibitor vitacoxib in dogs.

J. Mochel, Yeon-Jung Seo, Pan Sun, 2019, Journal of veterinary pharmacology and therapeutics.

Comparison of the pharmacokinetics of continuous and intermittent infusions of ampicillin-sulbactam in dogs with septic peritonitis.

Tara N. Hammond, J. Mochel, S. Stewart, 2022, American journal of veterinary research.

Non-Linear Mixed-Effects Pharmacokinetic Modeling of the Novel COX-2 Selective Inhibitor Vitacoxib in Cats

J. Mochel, Yeon-Jung Seo, Xingyuan Cao, 2020, Frontiers in Veterinary Science.

Investigation of Schirmer tear test-1 for measurement of tear production in cats in various environmental settings and with different test durations.

J. Mochel, June E. Olds, L. Sebbag, 2020, Journal of the American Veterinary Medical Association.